Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Lung Neoplasms × Nadroparin × Clear all

Phase

Phase NA 1 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Venous Thrombosis 2 Neoplasms 2 Venous Thromboembolism 1 Thromboembolism 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Neoplasm Metastasis 1 Lung Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Carboplatin 53 Cisplatin 51 Radiotherapy 33 Paclitaxel 30 Docetaxel 27 Gemcitabine 26 Pemetrexed 25 Etoposide 21 pembrolizumab 19 Vinorelbine 17 Drug Therapy 10 Radiosurgery 9 Magnetic Resonance Spectroscopy 9 Erlotinib Hydrochloride 9 durvalumab 8 Specimen Handling 8 Nivolumab 8 Gefitinib 6 Cyclophosphamide 6 Bevacizumab 6 Topotecan 5 Surgical Procedures, Operative 5 Standard of Care 5 Platinum 5 Dexamethasone 5 atezolizumab 4 Vinblastine 4 Immunoglobulin G 4 Ifosfamide 4 Doxorubicin 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01980849 2013-11-21

LCAN

Air Force Military Medical University, China

Phase 3 Unknown

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡